• About NeuroStar TMS^®
  • What is NeuroStar TMS Therapy^®?
  • How Does it Work?
  • Depression Treatment Guidelines
• NeuroStar TMS Therapy
  • Clinical Results
  • Safety Profile
  • What to Expect with Therapy
  • Patient Experiences
  • NeuroStar FAQs
  • Educational Video
• About Depression
  • Depression Symptoms
  • Treating Depression
  • Depression FAQs
  • NeuroStar for Depression
• Health Insurance Coverage
  • Reimbursement Support
• NeuroStar^® Resources
  • NeuroStar^® In The News
  • Recent Press Releases
  • Press Archive
  • Patient Education Webinars
  • NeuroStar^® Patient Corner
• Contact Us
  • General Contact Information

Safety Profile

NeuroStar TMS Therapy^® is a safe and easy to tolerate. Because it is not a drug that circulates throughout the body, NeuroStar TMS Therapy does not cause the side effects that patients often experience from antidepressant medications. NeuroStar TMS Therapy is free of side effects such as ^1,2:

 Common Drug Therapy Side Effects

 
NeuroStar TMS Therapy Side Effects
The most common side effect with NeuroStar TMS Therapy is temporary pain or discomfort at or near the treatment site during treatment. When this occurs it is temporary, and typically only during the first week of treatment. Other side effects include eye pain, toothache, muscle twitch, facial pain and pain of the skin (occurring > the 5% of patients and 2x the rate of placebo). In clinical trials, fewer than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to adverse events.

There is a rare risk of seizure with TMS Therapy. The estimated risk of seizure under ordinary clinical use is approximately 1 in 30,000 treatments.

Patients should notify their doctor if they experience worsening depression symptoms, signs or symptoms of suicidal behavior and/or unusual behavior. Family members and support individuals should also be aware of the need to observe patients and notify their treatment provider if symptoms worsen.

NeuroStar TMS Therapy should not be used with patients that have non-removable conductive metal or stimulator implants in or near the head or patients that have active or inactive implants such as deep brain stimulators, cochlear implants, and vagus nerve stimulators.

Click here to view full prescribing and safety information

Learn about a typical NeuroStar TMS Therapy treatment session

1. Janicak PG, O’Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69(2):222-232.
2. Data on file. Neuronetics, Inc.